Newsfeeds - Spark Newswire

2 minute read

Axsome Therapeutics Unusual Options Activity

Today, 1:12 PM

Someone with a lot of money to spend has taken a bullish stance on Axsome Therapeutics (NASDAQ:AXSM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

AXSM

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 1:12 PM

Gainers Cosmos Holdings (NASDAQ:COSM) stock increased by 20.5% to $0.52 during Monday’s pre-market session. The company’s market cap…

AXSM

3 minute read

DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday

By Lisa Levin

Today, 1:12 PM

U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session.

AAON

1 minute read

Earnings

Recap: Axsome Therapeutics Q3 Earnings

By Benzinga Insights

Today, 1:12 PM

Axsome Therapeutics (NASDAQ:AXSM) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

AXSM

13 minute read

Earnings

Earnings Scheduled For November 7, 2022

By Benzinga Insights

Today, 1:12 PM

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.

AAON

7 minute read

Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:12 PM

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

AFIB

2 minute read

Robinhood, Under Armour, HubSpot And Some Other Big Stocks Moving Higher On Thursday

By Lisa Levin

Today, 1:12 PM

U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Thursday. Here are some big stocks recording gains in today’s session.

AXSM

1 minute read

Relmada’s Trial Failure Removes Competitor Risk For This Company’s Newly Launched Depression Product

By Vandana Singh

Today, 1:12 PM

On Thursday, Relmada Therapeutics Inc (NASDAQ:RLMD) reported a failed Phase 3 Major Depressive Disorder monotherapy trial for its REL-1017. BofA analyst…

AXSM